Silverarc Capital Management »

Ark Etf Tr shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Ark Etf Tr shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Ark Etf Tr

Tip: Access up to 7 years of quarterly data

All positions including Ark Etf Tr held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ark Etf Tr by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $21M 500k 42.06

More positions owned by Silverarc Capital Management

Ascendis Pharma A/s Ord Shs (ASND)
Celcuity (CELC)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Immunome (IMNM)
Dianthus Therapeutics (DNTH)
Rhythm Pharmaceuticals (RYTM)
Oruka Therapeutics (ORKA)
Monte Rosa Therapeutics (GLUE)
Syndax Pharmaceuticals (SNDX)
Enliven Therapeutics (ELVN)
Immunovant (IMVT)
Erasca (ERAS)
Sagimet Biosciences Com Ser A (SGMT)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Silverarc Capital Management

Top funds holding Ark Etf Tr

Silverarc Capital Management
IMC-Chicago
Group One Trading
SG Americas Securities

View all funds holding Ark Etf Tr